Effects of Obesity on Rectus Femoris Muscle Thickness, Sarcopenia, Gait and Balance in Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-15

Study Completion Date

2023-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Research; It is a planned, non-invasive, controlled study in obese female volunteers and non-obese female volunteers. The population of the study consists of voluntarily non-obese women and obese women. Sarcopenia assets of individuals will be measured with the sarc-f questionnaire, and then muscle strength, muscle mass and physical performance tests will be measured. Then, rectus femoris muscle thickness will be measured with USG, and then walking and balance will be measured with ZEBRIS.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Different Methods to Measure Muscle Mass and Strength in a Population With Class II/III Obesity

NCT05732363

Obesity, Morbid

COMPLETED

Central Obesity in Cases of OAB

NCT03750604

Urologic Diseases Overactive Bladder Syndrome Obesity, Abdominal

COMPLETED NA

Ultrasound Lipolysis Versus Cryolipolysis On Lipid Profile Levels In Centrally Obese Middle Aged Men

NCT06658639

Ultrasound Lipolysis Cryolipolysis Lipid Profile +1 more

NOT_YET_RECRUITING NA

Effects of Radiofrequency on Located Adiposity

NCT02546778

Adiposity

COMPLETED NA

Different Surgical Modalities for Thigh Lipodystrophy Including Liposuction,Thigh Lift and Liposuction Assisted Thigh Lift

NCT03283475

Thigh Lipodystrophy

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenic Obesity Sarcopenia Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

non-obese women

After obtaining demographic information for women with a BMI of 18-27.9 kg/m2 for at least 6 months, Body Mass Index (BMI) will be calculated and the relationship between rectus femoris muscle thickness, sarcopenia, gait and balance will be evaluated and will be compared with obese group.

Ultrasonografi, Sarcopenia measurement, Zebris

Intervention Type DIAGNOSTIC_TEST

The rectus femoris muscle thickness of the participants will be performed in B mode via USG (Mindray-UMT 200,USA) with a multifrequency (7-15 MHz) linear probe and the measurement will be reported.

TANITA for sarcopenia, hand grip strength and walking speed will be evaluated.

Gait time-distance parameters and Static balance COP parameters (COP speed (cm/s) and COP length (cm)) will be recorded using Zebris™ FDM-2.

obese women

After obtaining demographic information in women with a BMI of 30-39.9 kg/m2, Body Mass Index (BMI) will be calculated and the relationship between obesity and rectus femoris muscle thickness, sarcopenia, gait and balance will be evaluated.

Ultrasonografi, Sarcopenia measurement, Zebris

Intervention Type DIAGNOSTIC_TEST

The rectus femoris muscle thickness of the participants will be performed in B mode via USG (Mindray-UMT 200,USA) with a multifrequency (7-15 MHz) linear probe and the measurement will be reported.

TANITA for sarcopenia, hand grip strength and walking speed will be evaluated.

Gait time-distance parameters and Static balance COP parameters (COP speed (cm/s) and COP length (cm)) will be recorded using Zebris™ FDM-2.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasonografi, Sarcopenia measurement, Zebris

The rectus femoris muscle thickness of the participants will be performed in B mode via USG (Mindray-UMT 200,USA) with a multifrequency (7-15 MHz) linear probe and the measurement will be reported.

TANITA for sarcopenia, hand grip strength and walking speed will be evaluated.

Gait time-distance parameters and Static balance COP parameters (COP speed (cm/s) and COP length (cm)) will be recorded using Zebris™ FDM-2.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being over 18 years old and female
* Volunteering and accepting to participate in the study
* BMI 30-39.9 kg/m2 in obese women (experimental group)
* BMI 18-27.9 kg/m2 in non-obese women (control group)
* Not having cardiorespiratory, neurological, orthopedic and metabolic disorders

Exclusion Criteria

* Being under 18 years old and male
* Having a BMI of 40.0 kg/m2 and above in obese women (experimental group)
* BMI 28.0 kg/m2 and above in non-obese women (control group)
* Having cardiorespiratory, neurological, orthopedic and metabolic disorders

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes